nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ACE—migraine	0.0678	0.101	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—ACE—migraine	0.0591	0.0878	CbGpPWpGaD
Icatibant—BDKRB2—trigeminal ganglion—migraine	0.0397	0.187	CbGeAlD
Icatibant—ANPEP—trigeminal ganglion—migraine	0.0248	0.116	CbGeAlD
Icatibant—BDKRB2—head—migraine	0.0194	0.0913	CbGeAlD
Icatibant—BDKRB2—Peptide GPCRs—EDNRA—migraine	0.0193	0.0287	CbGpPWpGaD
Icatibant—BDKRB2—nervous system—migraine	0.0184	0.0866	CbGeAlD
Icatibant—ANPEP—cardiovascular system—migraine	0.0179	0.0841	CbGeAlD
Icatibant—ANPEP—Peptide hormone metabolism—ACE—migraine	0.0178	0.0265	CbGpPWpGaD
Icatibant—BDKRB2—central nervous system—migraine	0.0177	0.0833	CbGeAlD
Icatibant—BDKRB2—cerebellum—migraine	0.0173	0.0814	CbGeAlD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2B—migraine	0.0156	0.0232	CbGpPWpGaD
Icatibant—BDKRB2—brain—migraine	0.0141	0.0662	CbGeAlD
Icatibant—BDKRB2—G alpha (i) signalling events—HTR1D—migraine	0.014	0.0208	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.014	0.0207	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.013	0.0193	CbGpPWpGaD
Icatibant—ANPEP—head—migraine	0.0121	0.0569	CbGeAlD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.0121	0.0179	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—RAMP1—migraine	0.0117	0.0173	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CALCRL—migraine	0.0117	0.0173	CbGpPWpGaD
Icatibant—ANPEP—nervous system—migraine	0.0115	0.054	CbGeAlD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.0111	0.0165	CbGpPWpGaD
Icatibant—ANPEP—central nervous system—migraine	0.0111	0.052	CbGeAlD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.0103	0.0153	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—TAC1—migraine	0.00964	0.0143	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—NPS—migraine	0.00964	0.0143	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—TAC1—migraine	0.00952	0.0141	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—NPS—migraine	0.00952	0.0141	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2C—migraine	0.00945	0.014	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—EDNRA—migraine	0.0092	0.0137	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—EDNRA—migraine	0.00908	0.0135	CbGpPWpGaD
Icatibant—ANPEP—brain—migraine	0.00878	0.0413	CbGeAlD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00862	0.0128	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00862	0.0128	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—HTR1B—migraine	0.00847	0.0126	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR1D—migraine	0.00847	0.0126	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00846	0.0126	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00823	0.0122	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—HTR1A—migraine	0.00815	0.0121	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2B—migraine	0.00787	0.0117	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00786	0.0117	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00757	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00731	0.0109	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00711	0.0106	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00674	0.01	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RAMP1—migraine	0.00658	0.00978	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CALCRL—migraine	0.00658	0.00978	CbGpPWpGaD
Icatibant—Injection site reaction—Valproic Acid—migraine	0.00656	0.0577	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00648	0.00963	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.0064	0.00951	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00638	0.00948	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00638	0.00948	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00626	0.0093	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00609	0.00905	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CALCRL—migraine	0.00598	0.00888	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RAMP1—migraine	0.00598	0.00888	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2A—migraine	0.0058	0.00861	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00548	0.00814	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00519	0.0077	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR1B—migraine	0.00513	0.00762	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR1A—migraine	0.00494	0.00733	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—TAC1—migraine	0.00486	0.00722	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—NPS—migraine	0.00486	0.00722	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR1D—migraine	0.00478	0.00711	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2C—migraine	0.00477	0.00708	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—EDNRA—migraine	0.00464	0.00689	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00448	0.00666	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CALCA—migraine	0.00446	0.00663	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2B—migraine	0.00445	0.00661	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR1D—migraine	0.00434	0.00645	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR7—migraine	0.00418	0.0062	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR2B—migraine	0.00404	0.006	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00384	0.0057	CbGpPWpGaD
Icatibant—Anaphylactic shock—Propranolol—migraine	0.00361	0.0317	CcSEcCtD
Icatibant—Nervous system disorder—Propranolol—migraine	0.00354	0.0311	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—RAMP1—migraine	0.00353	0.00525	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CALCRL—migraine	0.00353	0.00525	CbGpPWpGaD
Icatibant—Body temperature increased—Amitriptyline—migraine	0.00351	0.0308	CcSEcCtD
Icatibant—ANPEP—Metabolism of proteins—ACE—migraine	0.00337	0.005	CbGpPWpGaD
Icatibant—Anaphylactic shock—Verapamil—migraine	0.00332	0.0292	CcSEcCtD
Icatibant—Dizziness—Amitriptyline—migraine	0.00293	0.0258	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—HTR2A—migraine	0.00292	0.00434	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR1B—migraine	0.0029	0.0043	CbGpPWpGaD
Icatibant—Body temperature increased—Propranolol—migraine	0.00285	0.0251	CcSEcCtD
Icatibant—Rash—Amitriptyline—migraine	0.0028	0.0246	CcSEcCtD
Icatibant—Dermatitis—Amitriptyline—migraine	0.00279	0.0245	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—HTR1A—migraine	0.00279	0.00414	CbGpPWpGaD
Icatibant—Headache—Amitriptyline—migraine	0.00278	0.0244	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—TAC1—migraine	0.00275	0.00408	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—NPS—migraine	0.00275	0.00408	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2C—migraine	0.00269	0.004	CbGpPWpGaD
Icatibant—Hypersensitivity—Propranolol—migraine	0.00266	0.0234	CcSEcCtD
Icatibant—Nausea—Amitriptyline—migraine	0.00263	0.0231	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HTR1B—migraine	0.00263	0.00391	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—EDNRA—migraine	0.00262	0.00389	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR1D—migraine	0.00257	0.00381	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR1A—migraine	0.00253	0.00376	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CALCA—migraine	0.00252	0.00375	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TAC1—migraine	0.0025	0.00371	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPS—migraine	0.0025	0.00371	CbGpPWpGaD
Icatibant—Hypersensitivity—Verapamil—migraine	0.00245	0.0215	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HTR2C—migraine	0.00245	0.00363	CbGpPWpGaD
Icatibant—Dizziness—Propranolol—migraine	0.00239	0.021	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HTR2B—migraine	0.00239	0.00354	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—EDNRA—migraine	0.00238	0.00354	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR7—migraine	0.00236	0.00351	CbGpPWpGaD
Icatibant—Anaphylactic shock—Valproic Acid—migraine	0.00235	0.0207	CcSEcCtD
Icatibant—Nervous system disorder—Valproic Acid—migraine	0.00231	0.0203	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CALCA—migraine	0.00229	0.0034	CbGpPWpGaD
Icatibant—Rash—Propranolol—migraine	0.00228	0.02	CcSEcCtD
Icatibant—Dermatitis—Propranolol—migraine	0.00227	0.02	CcSEcCtD
Icatibant—Dizziness—Verapamil—migraine	0.0022	0.0193	CcSEcCtD
Icatibant—Nausea—Propranolol—migraine	0.00214	0.0188	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HTR7—migraine	0.00214	0.00318	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LRP1—migraine	0.0021	0.00312	CbGpPWpGaD
Icatibant—Anaphylactic shock—Timolol—migraine	0.0021	0.0184	CcSEcCtD
Icatibant—Rash—Verapamil—migraine	0.00209	0.0184	CcSEcCtD
Icatibant—Dermatitis—Verapamil—migraine	0.00209	0.0184	CcSEcCtD
Icatibant—Headache—Verapamil—migraine	0.00208	0.0183	CcSEcCtD
Icatibant—Nervous system disorder—Timolol—migraine	0.00206	0.0181	CcSEcCtD
Icatibant—Nausea—Verapamil—migraine	0.00197	0.0173	CcSEcCtD
Icatibant—Anaphylactic shock—Gabapentin—migraine	0.00195	0.0172	CcSEcCtD
Icatibant—Nervous system disorder—Gabapentin—migraine	0.00191	0.0168	CcSEcCtD
Icatibant—Body temperature increased—Valproic Acid—migraine	0.00186	0.0164	CcSEcCtD
Icatibant—Hypersensitivity—Valproic Acid—migraine	0.00174	0.0152	CcSEcCtD
Icatibant—Body temperature increased—Timolol—migraine	0.00166	0.0146	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2A—migraine	0.00165	0.00245	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOTCH4—migraine	0.00161	0.00239	CbGpPWpGaD
Icatibant—Nervous system disorder—Topiramate—migraine	0.00161	0.0142	CcSEcCtD
Icatibant—Dizziness—Valproic Acid—migraine	0.00156	0.0137	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HTR1B—migraine	0.00155	0.00231	CbGpPWpGaD
Icatibant—Hypersensitivity—Timolol—migraine	0.00154	0.0136	CcSEcCtD
Icatibant—Body temperature increased—Gabapentin—migraine	0.00154	0.0136	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—HTR2A—migraine	0.0015	0.00223	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR1A—migraine	0.0015	0.00222	CbGpPWpGaD
Icatibant—Rash—Valproic Acid—migraine	0.00148	0.013	CcSEcCtD
Icatibant—Dermatitis—Valproic Acid—migraine	0.00148	0.013	CcSEcCtD
Icatibant—Headache—Valproic Acid—migraine	0.00148	0.013	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TAC1—migraine	0.00147	0.00219	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPS—migraine	0.00147	0.00219	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PGR—migraine	0.00147	0.00219	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR2C—migraine	0.00145	0.00215	CbGpPWpGaD
Icatibant—Hypersensitivity—Gabapentin—migraine	0.00144	0.0126	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—EDNRA—migraine	0.00141	0.00209	CbGpPWpGaD
Icatibant—Nausea—Valproic Acid—migraine	0.0014	0.0123	CcSEcCtD
Icatibant—Dizziness—Timolol—migraine	0.00139	0.0122	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—NOTCH3—migraine	0.00137	0.00204	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CALCA—migraine	0.00135	0.00201	CbGpPWpGaD
Icatibant—Rash—Timolol—migraine	0.00132	0.0116	CcSEcCtD
Icatibant—Dermatitis—Timolol—migraine	0.00132	0.0116	CcSEcCtD
Icatibant—Headache—Timolol—migraine	0.00131	0.0115	CcSEcCtD
Icatibant—Body temperature increased—Topiramate—migraine	0.0013	0.0114	CcSEcCtD
Icatibant—Dizziness—Gabapentin—migraine	0.00129	0.0113	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HTR7—migraine	0.00127	0.00188	CbGpPWpGaD
Icatibant—Nausea—Timolol—migraine	0.00125	0.0109	CcSEcCtD
Icatibant—Rash—Gabapentin—migraine	0.00123	0.0108	CcSEcCtD
Icatibant—Dermatitis—Gabapentin—migraine	0.00123	0.0108	CcSEcCtD
Icatibant—Headache—Gabapentin—migraine	0.00122	0.0107	CcSEcCtD
Icatibant—Hypersensitivity—Topiramate—migraine	0.00121	0.0106	CcSEcCtD
Icatibant—Nausea—Gabapentin—migraine	0.00116	0.0102	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TGFBR2—migraine	0.00109	0.00162	CbGpPWpGaD
Icatibant—Dizziness—Topiramate—migraine	0.00109	0.00954	CcSEcCtD
Icatibant—Rash—Topiramate—migraine	0.00104	0.0091	CcSEcCtD
Icatibant—Dermatitis—Topiramate—migraine	0.00103	0.00909	CcSEcCtD
Icatibant—Headache—Topiramate—migraine	0.00103	0.00904	CcSEcCtD
Icatibant—Nausea—Topiramate—migraine	0.000976	0.00857	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—HTR2A—migraine	0.000887	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ESR1—migraine	0.000787	0.00117	CbGpPWpGaD
